Held on 18 August 2017
IOL Chemicals & Pharmaceuticals announced that the Board of directors of the Company at its meeting held on 18 August 2017 has taken note of increase in manufacturing capacity of the Ibuprofen from 6200 TPA to 7200 TPA by conversion of existing multipurpose plant.Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)